Non-CHO cell expression systems gain traction as faster, more flexible alternatives for biologics manufacturing.

Evolution is perhaps the most extraordinary story ever told—a tale spanning billions of years that connects every living thing on Earth through an intricate ...

Learn how BeSEC enables precise analysis of antibody aggregation and molecular weight through dual-angle light scattering.

Precision-fermented fats are the new invention that promises to be better for the heart. Here is exactly what it is, how it ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

FDA's elevated meeting status signals transition from biomarker data discussions to Accelerated Approval discussionsOS Therapies on track to complete clinical data submission by the end of Q1 2026New ...

Lululemon, Toray, Polygiene and Kyocera push performance textiles forward with sweat-concealing yarns, ultra-fine filaments and next-gen odor tech.

SAN CARLOS, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced financial results for the fourth quarter and full year ...

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application (sBLA) for ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been accepted and granted Priority Review in the US for the ...

The Forum on Microbial Threats hosts public workshops and supports various other events and publications produced by global ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.